15th Edition of International Conference on Healthcare

May 27-29, 2019 | Spain

Euroscicon is proud to host the 15th Edition of International conference on Healthcare taking place on May 27-29, 2019 in Barcelona, Spain. The Healthcare 2019 conference has become a premier forum to network, learn and engage with professionals, academicians, scholars, researchers and activists in creating a platform to discuss and disseminate meaningful messages, values and practices in the subject of health and primary care.

Spotlight

The Food and Drug Administration Safety and Innovation Act (FDASIA)1 of 2012 gave FDA authority to request data and information from the industry in advance of or in lieu of an inspection to identify potential risk for drug supply disruption, improve the efficiency and effectiveness of establishment inspections, and improve FDA’s evaluation of drug manufacturing and control operations.


OTHER PAST CONFERENCES

Medical Affairs Strategic Summit West (MASS West)

September 20-22, 2022 | USA

MASS West 2022 will provide a platform for Medical Affairs executives and professionals to share best practices, strategic insights, and collaborate to advance communication techniques.

4th International Conference on Medical and Health Sciences

June 8-9, 2022 | USA

Healthcare and medical studies were prevalent several decades ago. Several significant discoveries and inventions that acts as the fundamentalprinciples of today's modern research and healthcare are traced to be in the early 18th century.

AMIA 2022 Annual Symposium

November 5-9, 2022 | USA

The Annual Symposium builds on more than 45 years of sharing research and insights for leveraging health information and cutting-edge technologies to improve human health.

Rare Disease Select

September 13-14, 2022 | USA

Rare Disease Select is a premium, invitation-only event built for senior leaders across the pharmaceutical and biotech fields to provide practical insight on how outsourcing, decentralized trial strategies,

Spotlight

The Food and Drug Administration Safety and Innovation Act (FDASIA)1 of 2012 gave FDA authority to request data and information from the industry in advance of or in lieu of an inspection to identify potential risk for drug supply disruption, improve the efficiency and effectiveness of establishment inspections, and improve FDA’s evaluation of drug manufacturing and control operations.

resources